Spots Global Cancer Trial Database for Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials
Official Title: An Open Label Extension Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination With Other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study.
Study ID: NCT03207256
Study Description
Brief Summary: This is an open label compassionate use trial of Ublituximab and TGR-1202 in combination or as single agents in patients currently receiving treatment on Ublituximab and/or TGR-1202 trials with B-cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
TG Therapeutics Investigational Trial Site, Huntsville, Alabama, United States
TG Therapeutics Investigational Trial Site, Tucson, Arizona, United States
TG Therapeutics Investigational Trial Site, Fayetteville, Arkansas, United States
TG Therapeutics Investigational Trial Site, Duarte, California, United States
TG Therapeutics Investigational Trial Site, Fort Myers, Florida, United States
TG Therapeutics Investigational Trial Site, Atlanta, Georgia, United States
TG Therapeutics Investigational Trial Site, Fort Wayne, Indiana, United States
TG Therapeutics Investigational Trial Site, Coon Rapids, Minnesota, United States
TG Therapeutics Investigational Trial Site, Omaha, Nebraska, United States
TG Therapeutics Investigational Trial Site, Durham, North Carolina, United States
TG Therapeutics Investigational Site, Canton, Ohio, United States
TG Therapeutics Investigational Trial Site, Cincinnati, Ohio, United States
TG Therapeutics Investigational Trial Site, Nashville, Tennessee, United States
TG Therapeutics Investigational Trial Site, Denton, Texas, United States
TG Therapeutics Investigational Trial Site, San Antonio, Texas, United States
TG Therapeutics Investigational Trial Site, Seattle, Washington, United States
TG Therapeutics Investigational Trial Site, Milwaukee, Wisconsin, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
